Assessing Long-Term Maintenance of Efficacy With Tralokinumab Monotherapy in Patients With Moderate-to-Severe Atopic Dermatitis: Combined Results from Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials (ECZTRA 1 and 2). J of Skin 2021, 5 (6), s57. https://doi.org/10.25251/skin.5.supp.57.